1
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

1
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hemotransmissive Infections Testing Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-10C6021
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Hemotransmissive Infections Testing Market Insights Forecast to 2028
BUY CHAPTERS

Global Hemotransmissive Infections Testing Market Insights, Forecast to 2030

Code: QYRE-Auto-10C6021
Report
December 2024
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hemotransmissive Infections Testing Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Hemotransmissive Infections Testing Market

Hemotransmissive Infections Testing Market

Hemotransmissive Infections are the infections which are transferred through blood when infected person comes in contact. Severe diseases such as hepatitis C, hepatitis B and human immunodeficiency virus (HIV) are most common diseases spread via blood. Timely diagnosis of these diseases becomes important for their cure or management.
Market Analysis and Insights: Global Hemotransmissive Infections Testing Market
The global Hemotransmissive Infections Testing market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers:
This report presents an overview of global market for Hemotransmissive Infections Testing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Hemotransmissive Infections Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Hemotransmissive Infections Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hemotransmissive Infections Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Hemotransmissive Infections Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Hemotransmissive Infections Testing revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Hemotransmissive Infections Testing Market Report

Report Metric Details
Report Name Hemotransmissive Infections Testing Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
  • Hepatitis B virus (HBV) DNA Testing
  • Hepatitis C virus (HCV) RNA Testing
  • Human immunodeficiency virus (HIV) types 1 and 2 RNA Testing
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Vector-Best, Atlas Medical, Launch Diagnostics, Creative Diagnostics, Shanghai Chemtron Biotech, Oscar Medicare, ABON Biopharm, Bio-Rad Laboratories, Trinity Biotech Manufacturing, Adaltis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Hemotransmissive Infections Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Hemotransmissive Infections Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hemotransmissive Infections Testing revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Hemotransmissive Infections Testing Market report?

Ans: The main players in the Hemotransmissive Infections Testing Market are Vector-Best, Atlas Medical, Launch Diagnostics, Creative Diagnostics, Shanghai Chemtron Biotech, Oscar Medicare, ABON Biopharm, Bio-Rad Laboratories, Trinity Biotech Manufacturing, Adaltis

What are the Application segmentation covered in the Hemotransmissive Infections Testing Market report?

Ans: The Applications covered in the Hemotransmissive Infections Testing Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Hemotransmissive Infections Testing Market report?

Ans: The Types covered in the Hemotransmissive Infections Testing Market report are Hepatitis B virus (HBV) DNA Testing, Hepatitis C virus (HCV) RNA Testing, Human immunodeficiency virus (HIV) types 1 and 2 RNA Testing

Recommended Reports

Blood Transfusion Markets

Hematology Testing Devices

Infection Control & Testing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemotransmissive Infections Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Hepatitis B virus (HBV) DNA Testing
1.2.3 Hepatitis C virus (HCV) RNA Testing
1.2.4 Human immunodeficiency virus (HIV) types 1 and 2 RNA Testing
1.3 Market by Application
1.3.1 Global Hemotransmissive Infections Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hemotransmissive Infections Testing Market Perspective (2019-2030)
2.2 Global Hemotransmissive Infections Testing Growth Trends by Region
2.2.1 Hemotransmissive Infections Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hemotransmissive Infections Testing Historic Market Size by Region (2019-2024)
2.2.3 Hemotransmissive Infections Testing Forecasted Market Size by Region (2025-2030)
2.3 Hemotransmissive Infections Testing Market Dynamics
2.3.1 Hemotransmissive Infections Testing Industry Trends
2.3.2 Hemotransmissive Infections Testing Market Drivers
2.3.3 Hemotransmissive Infections Testing Market Challenges
2.3.4 Hemotransmissive Infections Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Hemotransmissive Infections Testing by Players
3.1.1 Global Hemotransmissive Infections Testing Revenue by Players (2019-2024)
3.1.2 Global Hemotransmissive Infections Testing Revenue Market Share by Players (2019-2024)
3.2 Global Hemotransmissive Infections Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Hemotransmissive Infections Testing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Hemotransmissive Infections Testing Market Concentration Ratio
3.4.1 Global Hemotransmissive Infections Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemotransmissive Infections Testing Revenue in 2023
3.5 Global Key Players of Hemotransmissive Infections Testing Head office and Area Served
3.6 Global Key Players of Hemotransmissive Infections Testing, Product and Application
3.7 Global Key Players of Hemotransmissive Infections Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hemotransmissive Infections Testing Breakdown Data by Type
4.1 Global Hemotransmissive Infections Testing Historic Market Size by Type (2019-2024)
4.2 Global Hemotransmissive Infections Testing Forecasted Market Size by Type (2025-2030)
5 Hemotransmissive Infections Testing Breakdown Data by Application
5.1 Global Hemotransmissive Infections Testing Historic Market Size by Application (2019-2024)
5.2 Global Hemotransmissive Infections Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hemotransmissive Infections Testing Market Size (2019-2030)
6.2 North America Hemotransmissive Infections Testing Market Size by Type
6.2.1 North America Hemotransmissive Infections Testing Market Size by Type (2019-2024)
6.2.2 North America Hemotransmissive Infections Testing Market Size by Type (2025-2030)
6.2.3 North America Hemotransmissive Infections Testing Market Share by Type (2019-2030)
6.3 North America Hemotransmissive Infections Testing Market Size by Application
6.3.1 North America Hemotransmissive Infections Testing Market Size by Application (2019-2024)
6.3.2 North America Hemotransmissive Infections Testing Market Size by Application (2025-2030)
6.3.3 North America Hemotransmissive Infections Testing Market Share by Application (2019-2030)
6.4 North America Hemotransmissive Infections Testing Market Size by Country
6.4.1 North America Hemotransmissive Infections Testing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Hemotransmissive Infections Testing Market Size by Country (2019-2024)
6.4.3 North America Hemotransmissive Infections Testing Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Hemotransmissive Infections Testing Market Size (2019-2030)
7.2 Europe Hemotransmissive Infections Testing Market Size by Type
7.2.1 Europe Hemotransmissive Infections Testing Market Size by Type (2019-2024)
7.2.2 Europe Hemotransmissive Infections Testing Market Size by Type (2025-2030)
7.2.3 Europe Hemotransmissive Infections Testing Market Share by Type (2019-2030)
7.3 Europe Hemotransmissive Infections Testing Market Size by Application
7.3.1 Europe Hemotransmissive Infections Testing Market Size by Application (2019-2024)
7.3.2 Europe Hemotransmissive Infections Testing Market Size by Application (2025-2030)
7.3.3 Europe Hemotransmissive Infections Testing Market Share by Application (2019-2030)
7.4 Europe Hemotransmissive Infections Testing Market Size by Country
7.4.1 Europe Hemotransmissive Infections Testing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Hemotransmissive Infections Testing Market Size by Country (2019-2024)
7.4.3 Europe Hemotransmissive Infections Testing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Hemotransmissive Infections Testing Market Size (2019-2030)
8.2 China Hemotransmissive Infections Testing Market Size by Type
8.2.1 China Hemotransmissive Infections Testing Market Size by Type (2019-2024)
8.2.2 China Hemotransmissive Infections Testing Market Size by Type (2025-2030)
8.2.3 China Hemotransmissive Infections Testing Market Share by Type (2019-2030)
8.3 China Hemotransmissive Infections Testing Market Size by Application
8.3.1 China Hemotransmissive Infections Testing Market Size by Application (2019-2024)
8.3.2 China Hemotransmissive Infections Testing Market Size by Application (2025-2030)
8.3.3 China Hemotransmissive Infections Testing Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Hemotransmissive Infections Testing Market Size (2019-2030)
9.2 Asia Hemotransmissive Infections Testing Market Size by Type
9.2.1 Asia Hemotransmissive Infections Testing Market Size by Type (2019-2024)
9.2.2 Asia Hemotransmissive Infections Testing Market Size by Type (2025-2030)
9.2.3 Asia Hemotransmissive Infections Testing Market Share by Type (2019-2030)
9.3 Asia Hemotransmissive Infections Testing Market Size by Application
9.3.1 Asia Hemotransmissive Infections Testing Market Size by Application (2019-2024)
9.3.2 Asia Hemotransmissive Infections Testing Market Size by Application (2025-2030)
9.3.3 Asia Hemotransmissive Infections Testing Market Share by Application (2019-2030)
9.4 Asia Hemotransmissive Infections Testing Market Size by Region
9.4.1 Asia Hemotransmissive Infections Testing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Hemotransmissive Infections Testing Market Size by Region (2019-2024)
9.4.3 Asia Hemotransmissive Infections Testing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Hemotransmissive Infections Testing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Hemotransmissive Infections Testing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Hemotransmissive Infections Testing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Hemotransmissive Infections Testing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Hemotransmissive Infections Testing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Hemotransmissive Infections Testing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Hemotransmissive Infections Testing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Hemotransmissive Infections Testing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Hemotransmissive Infections Testing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Hemotransmissive Infections Testing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Hemotransmissive Infections Testing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Hemotransmissive Infections Testing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Hemotransmissive Infections Testing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Vector-Best
11.1.1 Vector-Best Company Details
11.1.2 Vector-Best Business Overview
11.1.3 Vector-Best Hemotransmissive Infections Testing Introduction
11.1.4 Vector-Best Revenue in Hemotransmissive Infections Testing Business (2019-2024)
11.1.5 Vector-Best Recent Developments
11.2 Atlas Medical
11.2.1 Atlas Medical Company Details
11.2.2 Atlas Medical Business Overview
11.2.3 Atlas Medical Hemotransmissive Infections Testing Introduction
11.2.4 Atlas Medical Revenue in Hemotransmissive Infections Testing Business (2019-2024)
11.2.5 Atlas Medical Recent Developments
11.3 Launch Diagnostics
11.3.1 Launch Diagnostics Company Details
11.3.2 Launch Diagnostics Business Overview
11.3.3 Launch Diagnostics Hemotransmissive Infections Testing Introduction
11.3.4 Launch Diagnostics Revenue in Hemotransmissive Infections Testing Business (2019-2024)
11.3.5 Launch Diagnostics Recent Developments
11.4 Creative Diagnostics
11.4.1 Creative Diagnostics Company Details
11.4.2 Creative Diagnostics Business Overview
11.4.3 Creative Diagnostics Hemotransmissive Infections Testing Introduction
11.4.4 Creative Diagnostics Revenue in Hemotransmissive Infections Testing Business (2019-2024)
11.4.5 Creative Diagnostics Recent Developments
11.5 Shanghai Chemtron Biotech
11.5.1 Shanghai Chemtron Biotech Company Details
11.5.2 Shanghai Chemtron Biotech Business Overview
11.5.3 Shanghai Chemtron Biotech Hemotransmissive Infections Testing Introduction
11.5.4 Shanghai Chemtron Biotech Revenue in Hemotransmissive Infections Testing Business (2019-2024)
11.5.5 Shanghai Chemtron Biotech Recent Developments
11.6 Oscar Medicare
11.6.1 Oscar Medicare Company Details
11.6.2 Oscar Medicare Business Overview
11.6.3 Oscar Medicare Hemotransmissive Infections Testing Introduction
11.6.4 Oscar Medicare Revenue in Hemotransmissive Infections Testing Business (2019-2024)
11.6.5 Oscar Medicare Recent Developments
11.7 ABON Biopharm
11.7.1 ABON Biopharm Company Details
11.7.2 ABON Biopharm Business Overview
11.7.3 ABON Biopharm Hemotransmissive Infections Testing Introduction
11.7.4 ABON Biopharm Revenue in Hemotransmissive Infections Testing Business (2019-2024)
11.7.5 ABON Biopharm Recent Developments
11.8 Bio-Rad Laboratories
11.8.1 Bio-Rad Laboratories Company Details
11.8.2 Bio-Rad Laboratories Business Overview
11.8.3 Bio-Rad Laboratories Hemotransmissive Infections Testing Introduction
11.8.4 Bio-Rad Laboratories Revenue in Hemotransmissive Infections Testing Business (2019-2024)
11.8.5 Bio-Rad Laboratories Recent Developments
11.9 Trinity Biotech Manufacturing
11.9.1 Trinity Biotech Manufacturing Company Details
11.9.2 Trinity Biotech Manufacturing Business Overview
11.9.3 Trinity Biotech Manufacturing Hemotransmissive Infections Testing Introduction
11.9.4 Trinity Biotech Manufacturing Revenue in Hemotransmissive Infections Testing Business (2019-2024)
11.9.5 Trinity Biotech Manufacturing Recent Developments
11.10 Adaltis
11.10.1 Adaltis Company Details
11.10.2 Adaltis Business Overview
11.10.3 Adaltis Hemotransmissive Infections Testing Introduction
11.10.4 Adaltis Revenue in Hemotransmissive Infections Testing Business (2019-2024)
11.10.5 Adaltis Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Hemotransmissive Infections Testing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Hepatitis B virus (HBV) DNA Testing
    Table 3. Key Players of Hepatitis C virus (HCV) RNA Testing
    Table 4. Key Players of Human immunodeficiency virus (HIV) types 1 and 2 RNA Testing
    Table 5. Global Hemotransmissive Infections Testing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Hemotransmissive Infections Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Hemotransmissive Infections Testing Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Hemotransmissive Infections Testing Market Share by Region (2019-2024)
    Table 9. Global Hemotransmissive Infections Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Hemotransmissive Infections Testing Market Share by Region (2025-2030)
    Table 11. Hemotransmissive Infections Testing Market Trends
    Table 12. Hemotransmissive Infections Testing Market Drivers
    Table 13. Hemotransmissive Infections Testing Market Challenges
    Table 14. Hemotransmissive Infections Testing Market Restraints
    Table 15. Global Hemotransmissive Infections Testing Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Hemotransmissive Infections Testing Revenue Share by Players (2019-2024)
    Table 17. Global Top Hemotransmissive Infections Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemotransmissive Infections Testing as of 2023)
    Table 18. Global Hemotransmissive Infections Testing Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Hemotransmissive Infections Testing Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Hemotransmissive Infections Testing, Headquarters and Area Served
    Table 21. Global Key Players of Hemotransmissive Infections Testing, Product and Application
    Table 22. Global Key Players of Hemotransmissive Infections Testing, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Hemotransmissive Infections Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Hemotransmissive Infections Testing Revenue Market Share by Type (2019-2024)
    Table 26. Global Hemotransmissive Infections Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Hemotransmissive Infections Testing Revenue Market Share by Type (2025-2030)
    Table 28. Global Hemotransmissive Infections Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Hemotransmissive Infections Testing Revenue Share by Application (2019-2024)
    Table 30. Global Hemotransmissive Infections Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Hemotransmissive Infections Testing Revenue Share by Application (2025-2030)
    Table 32. North America Hemotransmissive Infections Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Hemotransmissive Infections Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Hemotransmissive Infections Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Hemotransmissive Infections Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Hemotransmissive Infections Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Hemotransmissive Infections Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Hemotransmissive Infections Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Hemotransmissive Infections Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Hemotransmissive Infections Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Hemotransmissive Infections Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Hemotransmissive Infections Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Hemotransmissive Infections Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Hemotransmissive Infections Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Hemotransmissive Infections Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Hemotransmissive Infections Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Hemotransmissive Infections Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Hemotransmissive Infections Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Hemotransmissive Infections Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Hemotransmissive Infections Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Hemotransmissive Infections Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Hemotransmissive Infections Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Hemotransmissive Infections Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Hemotransmissive Infections Testing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Hemotransmissive Infections Testing Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Hemotransmissive Infections Testing Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Hemotransmissive Infections Testing Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Hemotransmissive Infections Testing Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Hemotransmissive Infections Testing Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Hemotransmissive Infections Testing Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Hemotransmissive Infections Testing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Hemotransmissive Infections Testing Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Hemotransmissive Infections Testing Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Vector-Best Company Details
    Table 65. Vector-Best Business Overview
    Table 66. Vector-Best Hemotransmissive Infections Testing Product
    Table 67. Vector-Best Revenue in Hemotransmissive Infections Testing Business (2019-2024) & (US$ Million)
    Table 68. Vector-Best Recent Developments
    Table 69. Atlas Medical Company Details
    Table 70. Atlas Medical Business Overview
    Table 71. Atlas Medical Hemotransmissive Infections Testing Product
    Table 72. Atlas Medical Revenue in Hemotransmissive Infections Testing Business (2019-2024) & (US$ Million)
    Table 73. Atlas Medical Recent Developments
    Table 74. Launch Diagnostics Company Details
    Table 75. Launch Diagnostics Business Overview
    Table 76. Launch Diagnostics Hemotransmissive Infections Testing Product
    Table 77. Launch Diagnostics Revenue in Hemotransmissive Infections Testing Business (2019-2024) & (US$ Million)
    Table 78. Launch Diagnostics Recent Developments
    Table 79. Creative Diagnostics Company Details
    Table 80. Creative Diagnostics Business Overview
    Table 81. Creative Diagnostics Hemotransmissive Infections Testing Product
    Table 82. Creative Diagnostics Revenue in Hemotransmissive Infections Testing Business (2019-2024) & (US$ Million)
    Table 83. Creative Diagnostics Recent Developments
    Table 84. Shanghai Chemtron Biotech Company Details
    Table 85. Shanghai Chemtron Biotech Business Overview
    Table 86. Shanghai Chemtron Biotech Hemotransmissive Infections Testing Product
    Table 87. Shanghai Chemtron Biotech Revenue in Hemotransmissive Infections Testing Business (2019-2024) & (US$ Million)
    Table 88. Shanghai Chemtron Biotech Recent Developments
    Table 89. Oscar Medicare Company Details
    Table 90. Oscar Medicare Business Overview
    Table 91. Oscar Medicare Hemotransmissive Infections Testing Product
    Table 92. Oscar Medicare Revenue in Hemotransmissive Infections Testing Business (2019-2024) & (US$ Million)
    Table 93. Oscar Medicare Recent Developments
    Table 94. ABON Biopharm Company Details
    Table 95. ABON Biopharm Business Overview
    Table 96. ABON Biopharm Hemotransmissive Infections Testing Product
    Table 97. ABON Biopharm Revenue in Hemotransmissive Infections Testing Business (2019-2024) & (US$ Million)
    Table 98. ABON Biopharm Recent Developments
    Table 99. Bio-Rad Laboratories Company Details
    Table 100. Bio-Rad Laboratories Business Overview
    Table 101. Bio-Rad Laboratories Hemotransmissive Infections Testing Product
    Table 102. Bio-Rad Laboratories Revenue in Hemotransmissive Infections Testing Business (2019-2024) & (US$ Million)
    Table 103. Bio-Rad Laboratories Recent Developments
    Table 104. Trinity Biotech Manufacturing Company Details
    Table 105. Trinity Biotech Manufacturing Business Overview
    Table 106. Trinity Biotech Manufacturing Hemotransmissive Infections Testing Product
    Table 107. Trinity Biotech Manufacturing Revenue in Hemotransmissive Infections Testing Business (2019-2024) & (US$ Million)
    Table 108. Trinity Biotech Manufacturing Recent Developments
    Table 109. Adaltis Company Details
    Table 110. Adaltis Business Overview
    Table 111. Adaltis Hemotransmissive Infections Testing Product
    Table 112. Adaltis Revenue in Hemotransmissive Infections Testing Business (2019-2024) & (US$ Million)
    Table 113. Adaltis Recent Developments
    Table 114. Research Programs/Design for This Report
    Table 115. Key Data Information from Secondary Sources
    Table 116. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Hemotransmissive Infections Testing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Hemotransmissive Infections Testing Market Share by Type: 2023 VS 2030
    Figure 3. Hepatitis B virus (HBV) DNA Testing Features
    Figure 4. Hepatitis C virus (HCV) RNA Testing Features
    Figure 5. Human immunodeficiency virus (HIV) types 1 and 2 RNA Testing Features
    Figure 6. Global Hemotransmissive Infections Testing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Hemotransmissive Infections Testing Market Share by Application: 2023 VS 2030
    Figure 8. Hospital Case Studies
    Figure 9. Clinic Case Studies
    Figure 10. Others Case Studies
    Figure 11. Hemotransmissive Infections Testing Report Years Considered
    Figure 12. Global Hemotransmissive Infections Testing Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Hemotransmissive Infections Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Hemotransmissive Infections Testing Market Share by Region: 2023 VS 2030
    Figure 15. Global Hemotransmissive Infections Testing Market Share by Players in 2023
    Figure 16. Global Top Hemotransmissive Infections Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemotransmissive Infections Testing as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Hemotransmissive Infections Testing Revenue in 2023
    Figure 18. North America Hemotransmissive Infections Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Hemotransmissive Infections Testing Market Share by Type (2019-2030)
    Figure 20. North America Hemotransmissive Infections Testing Market Share by Application (2019-2030)
    Figure 21. North America Hemotransmissive Infections Testing Market Share by Country (2019-2030)
    Figure 22. United States Hemotransmissive Infections Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Hemotransmissive Infections Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Hemotransmissive Infections Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Hemotransmissive Infections Testing Market Share by Type (2019-2030)
    Figure 26. Europe Hemotransmissive Infections Testing Market Share by Application (2019-2030)
    Figure 27. Europe Hemotransmissive Infections Testing Market Share by Country (2019-2030)
    Figure 28. Germany Hemotransmissive Infections Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Hemotransmissive Infections Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Hemotransmissive Infections Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Hemotransmissive Infections Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Hemotransmissive Infections Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Hemotransmissive Infections Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Hemotransmissive Infections Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Hemotransmissive Infections Testing Market Share by Type (2019-2030)
    Figure 36. China Hemotransmissive Infections Testing Market Share by Application (2019-2030)
    Figure 37. Asia Hemotransmissive Infections Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Hemotransmissive Infections Testing Market Share by Type (2019-2030)
    Figure 39. Asia Hemotransmissive Infections Testing Market Share by Application (2019-2030)
    Figure 40. Asia Hemotransmissive Infections Testing Market Share by Region (2019-2030)
    Figure 41. Japan Hemotransmissive Infections Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Hemotransmissive Infections Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Hemotransmissive Infections Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Hemotransmissive Infections Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Hemotransmissive Infections Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Hemotransmissive Infections Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Hemotransmissive Infections Testing Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Hemotransmissive Infections Testing Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Hemotransmissive Infections Testing Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Hemotransmissive Infections Testing Market Share by Country (2019-2030)
    Figure 51. Brazil Hemotransmissive Infections Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Hemotransmissive Infections Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Hemotransmissive Infections Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Hemotransmissive Infections Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Hemotransmissive Infections Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Hemotransmissive Infections Testing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Vector-Best Revenue Growth Rate in Hemotransmissive Infections Testing Business (2019-2024)
    Figure 58. Atlas Medical Revenue Growth Rate in Hemotransmissive Infections Testing Business (2019-2024)
    Figure 59. Launch Diagnostics Revenue Growth Rate in Hemotransmissive Infections Testing Business (2019-2024)
    Figure 60. Creative Diagnostics Revenue Growth Rate in Hemotransmissive Infections Testing Business (2019-2024)
    Figure 61. Shanghai Chemtron Biotech Revenue Growth Rate in Hemotransmissive Infections Testing Business (2019-2024)
    Figure 62. Oscar Medicare Revenue Growth Rate in Hemotransmissive Infections Testing Business (2019-2024)
    Figure 63. ABON Biopharm Revenue Growth Rate in Hemotransmissive Infections Testing Business (2019-2024)
    Figure 64. Bio-Rad Laboratories Revenue Growth Rate in Hemotransmissive Infections Testing Business (2019-2024)
    Figure 65. Trinity Biotech Manufacturing Revenue Growth Rate in Hemotransmissive Infections Testing Business (2019-2024)
    Figure 66. Adaltis Revenue Growth Rate in Hemotransmissive Infections Testing Business (2019-2024)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart